Cite
HARVARD Citation
Lu, H. et al. (2021). Rosiglitazone Suppresses Renal Crystal Deposition by Ameliorating Tubular Injury Resulted from Oxidative Stress and Inflammatory Response via Promoting the Nrf2/HO-1 Pathway and Shifting Macrophage Polarization. Oxidative medicine and cellular longevity. p. . [Online].